<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket2016111-15</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-7966</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Редакционные материалы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Editorial note</subject></subj-group></article-categories><title-group><article-title>По материалам клинических рекомендаций Европейской Тиреоидной Ассоциации по диагностике и лечению субклинического тиреотоксикоза</article-title><trans-title-group xml:lang="en"><trans-title>Discussion about European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фадеев</surname><given-names>Валентин Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Fadeyev</surname><given-names>Valentin V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заведующий кафедрой эндокринологии ГБОУ ВПО “Первый МГМУ им. И.М. Сеченова”</p></bio><bio xml:lang="en"><p>MD, PhD, professor, Head of the Endocrinology Department of Medical faculty</p></bio><email xlink:type="simple">walfad@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО “Первый московский государственный медицинский университет имени И.М. Сеченова”, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>22</day><month>06</month><year>2016</year></pub-date><volume>12</volume><issue>1</issue><fpage>11</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фадеев В.В., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Фадеев В.В.</copyright-holder><copyright-holder xml:lang="en">Fadeyev V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/7966">https://www.cet-endojournals.ru/jour/article/view/7966</self-uri><abstract><p>В статье обсуждаются рекомендации Европейской тиреоидной ассоциации по диагностике и лечению субклинического тиреотоксикоза.</p></abstract><trans-abstract xml:lang="en"><p>The article discusses European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>щитовидная железа</kwd><kwd>тиреотоксикоз</kwd><kwd>гипертиреоз</kwd><kwd>болезнь Грейвса</kwd><kwd>многоузловой токсический зоб</kwd></kwd-group><kwd-group xml:lang="en"><kwd>thyroid</kwd><kwd>hyperthyroidism</kwd><kwd>thyrotoxicosis</kwd><kwd>Graves’ disease</kwd><kwd>toxic multinodular goiter</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. European Thyroid Journal. 2015;4(3):149-163. doi: 10.1159/000438750.</mixed-citation><mixed-citation xml:lang="en">Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. European Thyroid Journal. 2015;4(3):149-163. doi: 10.1159/000438750.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
